@article{JTD17467,
author = {Anamika Chatterjee and Christina Feldmann and Jasmin S. Hanke and Marcel Ricklefs and Malakh Shrestha and Guenes Dogan and Axel Haverich and Jan D. Schmitto},
title = {The momentum of HeartMate 3: a novel active magnetically levitated centrifugal left ventricular assist device (LVAD)},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {Suppl 15},
year = {2017},
keywords = {},
abstract = {Left ventricular assist devices (LVADs) are emerging as the treatment of choice for advanced heart failure due to the dearth of healthy donor hearts for cardiac transplantation. The HeartMate 3 LVAD is a novel centrifugal pump which was developed to provide hemodynamic support in heart failure patients, either as a bridge to transplant (BTT), myocardial recovery, or as destination therapy (DT). Technological and clinical advancements have led to optimized hemocompatibility and development of less invasive surgical procedures for the implantation of this pump. The worldwide first implantation of the HeartMate 3 was performed by Prof. Schmitto and his team at Hannover Medical School, Germany in 2014, paving the way for subsequent surgical developments. This article summarizes the advanced technological and clinical aspects of the HeartMate 3 and outlines future technical developments for safe and effective treatment of advanced heart failure.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/17467}
}